Jinghao P. Liu

No. 154 An'shan Road
Tianjin, 300052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Preliminary Analysis of Tumor Immune Microenvironment Characteristics in Lung Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy  Based on Single-cell Transcriptomics

Preliminary Analysis of Tumor Immune Microenvironment Characteristics in Lung Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy  Based on Single-cell Transcriptomics

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 13, 2026

Establishment, functional dissection, and single-cell transcriptomal characteristics of patient-derived pulmonary sarcomatoid carcinoma organoids.

Establishment, functional dissection, and single-cell transcriptomal characteristics of patient-derived pulmonary sarcomatoid carcinoma organoids.

Journal: Frontiers in oncology

Published: April 28, 2026

Integrated genomic and immunophenotypic profiling reveals monoclonal origin, smoking-driven evolution and heterogeneous microenvironment in pulmonary adenosquamous carcinoma.

Integrated genomic and immunophenotypic profiling reveals monoclonal origin, smoking-driven evolution and heterogeneous microenvironment in pulmonary adenosquamous carcinoma.

Journal: Frontiers in immunology

Published: April 25, 2026

Evaluation of surgical treatment outcomes and development of a prognostic model for patients with small cell lung cancer.

Evaluation of surgical treatment outcomes and development of a prognostic model for patients with small cell lung cancer.

Journal: Future oncology (London, England)

Published: February 10, 2026

Application Practice of AI Empowering Post-discharge Specialized Disease Management in Postoperative Rehabilitation of the Lung Cancer Patients Undergoing Surgery

Application Practice of AI Empowering Post-discharge Specialized Disease Management in Postoperative Rehabilitation of the Lung Cancer Patients Undergoing Surgery

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: April 10, 2025

Anlotinib Plus Osimertinib in Osimertinib-Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective Study.

Anlotinib Plus Osimertinib in Osimertinib-Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective Study.

Journal: Thoracic cancer

Published: December 10, 2024

Clinical features and lymphocyte subtypes in patients with IgG4-related diseases

Clinical features and lymphocyte subtypes in patients with IgG4-related diseases

Journal: Zhonghua nei ke za zhi

Published: April 01, 2024

Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer.

Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer.

Journal: Frontiers in immunology

Published: January 11, 2024

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

Journal: Journal of Cancer

Published: November 06, 2023

Genomic analysis of hypoxia and mitophagy related genes with prognosis and characterization of the immune microenvironment in LUAD.

Genomic analysis of hypoxia and mitophagy related genes with prognosis and characterization of the immune microenvironment in LUAD.

Journal: Journal of Cancer

Published: November 01, 2023

Seven preoperative factors have strong predictive value for postoperative pneumonia in patients undergoing thoracoscopic lung cancer surgery.

Seven preoperative factors have strong predictive value for postoperative pneumonia in patients undergoing thoracoscopic lung cancer surgery.

Journal: Translational lung cancer research

Published: August 08, 2023

Apatinib added when NSCLC patients get slow progression with EGFR-TKI: A prospective, single-arm study.

Apatinib added when NSCLC patients get slow progression with EGFR-TKI: A prospective, single-arm study.

Journal: Cancer medicine

Published: June 02, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026